ACTON, Mass. --(BUSINESS WIRE)--May 6, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended March 31, 2021 .
ACTON, Mass. --(BUSINESS WIRE)--May 4, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at the virtual BofA Securities 2021 Health Care Conference on
ACTON, Mass. --(BUSINESS WIRE)--May 3, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the publication of its 2020 Sustainability Report.
ACTON, Mass. --(BUSINESS WIRE)--Apr. 29, 2021-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the pricing of a $500 million senior secured term loan B facility (the term
ACTON, Mass. --(BUSINESS WIRE)--Apr. 19, 2021-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that it has launched the syndication of new senior secured credit facilities,
ACTON, Mass. --(BUSINESS WIRE)--Apr. 5, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced plans to release its financial results for the first quarter of 2021 on May 6,
ACTON, Mass. --(BUSINESS WIRE)--Mar. 20, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced positive results from the first pivotal trial for the Omnipod ® 5 Automated
Omnipod 5 is the world’s first tubeless, wearable automated insulin delivery system that continuously adapts insulin delivery based on glucose levels and trends ACTON, Mass. --(BUSINESS WIRE)--Mar. 16, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in
Represents 5th Consecutive Year of Over 20% Revenue Growth; Record Quarterly Revenue ACTON, Mass. --(BUSINESS WIRE)--Feb. 23, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System
ACTON, Mass. --(BUSINESS WIRE)--Feb. 8, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming virtual investor conferences: The Citi
ACTON, Mass. --(BUSINESS WIRE)--Jan. 18, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the launch of the Omnipod DASH ® Insulin Management
ACTON, Mass. --(BUSINESS WIRE)--Jan. 11, 2021-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year of 2020 on
ACTON, Mass. --(BUSINESS WIRE)--Dec. 21, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 39 th Annual J.P.
ACTON, Mass. --(BUSINESS WIRE)--Nov. 9, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming virtual investor conferences: The
Includes Total Omnipod ® Revenue Growth of 20% ACTON, Mass. --(BUSINESS WIRE)--Nov. 4, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial
